EP4178600A1

EP4178600A1 - <smallcaps/>? ? ?glaucium? ? ? ? ?a veterinary composition containing as an active substance either glaucine or an extract from a herb of thesp., a method of manufacturing thereof, and its use for the prevention and/or treatment of diseases caused by protozoa of <ns1:i>apicomplexa</ns1:i>?phylum in animals

Info

Publication number: EP4178600A1
Application number: EP21759382.1A
Authority: EP
Inventors: Henryk ROZANSKI; Hubert IWINSKI
Original assignee: Adifeed Sp Z O O
Current assignee: Adifeed Sp Z O O
Priority date: 2020-07-13
Filing date: 2021-07-13
Publication date: 2023-05-17
Also published as: WO2022013740A1; PL434649A1

Abstract

The subject of invention is a veterinary composition containing as an active substance either glaucine or an extract from a herb of the Glaucium sp., characterised in that said active substance is in a complex with a mixture of organic acids comprising four acids selected from the group comprising: valeric acid, isovaleric acid, lactic acid, butyric acid, acetic acid, propionic acid, formic acid, benzoic acid, pelargonic acid, salicylic acid, malonic acid, citric acid, phthalic acid, tartaric acid, oxalic acid, malic acid, shikimic acid, fumaric acid, mandelic acid cinnamic or derivatives thereof and a metal selected from the group comprising molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, their salts or oxides for the treatment and/or prevention of diseases caused by protozoa of Apicomplexa phylum in animals. Another subject of invention is a method of manufacturing a veterinary composition for the treatment and/or prevention of diseases caused by protozoa of Apicomplexa phylum in animals, containing either glaucine or an extract from a herb the Glaucium sp. as the active substance.

Description

A veterinary composition containing as an active substance either glaucine or an extract from a herb of the Glaucium sp., a method of manufacturing thereof, and its use for the prevention and/or treatment of diseases caused by protozoa of Apicomplexa phylum in animals

The invention relates to a veterinary composition containing as an active substance either glaucine or an extract from a herb of the Glaucium sp., a method of manufacturing thereof, and its use for the prevention and/or treatment of diseases caused by protozoa of Apicomplexa phylum in animals.

The published literature indicates that some secondary plant metabolites, such as phytoncides and phytoalexins, have potential lethal and static properties against protozoa, bacteria, viruses and fungi.

Phytoncides (gr. phyton - plant; cid - syllable indicating the cidal properties) were first detected by Soviet researchers in 1928-1930. The greatest achievements in the study of phytoncides are: G.I. Nilov, B. P. Tokin (1900-1984), A. Filatov and I. Torontsev. The term and definition of phytoncides were introduced by B.P. Tokin. Phytoncides are substances secreted and excreted by higher plants iCormophytd) with antibacterial, protozoal and fungicidal activity. Phytoncides are the equivalent of antibiotics, produced by bacteria, fungi and lichens ( Tariq , S., S. Wani, W. Rasool, K. Shafi, M. A. Bhat, A. Prabhakar, A. H. Shalla and M. A. Rather (2019). "A comprehensive review of the antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial pathogens. " Microbial Pathogenesis 134: 103580).

They are chemically very diverse. Phytoncides are in gaseous, crystalline and liquid forms. Many of them sublimate and boil at low temperatures, in the range of 30 °C. According to B.M. Kozo-Polianski, the volatile fractions of phytoncides are the plant's first line of defence, while non-volatile tissue phytoncides being the second line of defence. In the literature there is a confusion regarding the terminology of chemical compounds involved in plant disease resistance processes. Related to the issue of phytoncides are the terms phytoalexins, prohibitin, inhibitin and postinhibitin. In 1960, Cruickshank and Perrin first isolated and identified the phytoalexin pisatin from Pisum sativum (pea). In 1973 J. L. Ingham published an interesting division of the factors of resistance of higher plants to infection ( J.L . Ingham J. L., Disease resistance in higher plants. The concept of pre-infectional and post-infectional resistance, “Phytopath. Z. ” 1973, 78, p. 314 335 ), wherein:

Prohibitins are metabolites that limit or completely inhibit the growth of microorganisms. They exist constantly in plant tissues in unchanging concentration, e.g. berberine (alkaloid), isoflavones, catechins.

Inhibitins are metabolites whose content in cells increases after infection, e.g. chlorogenic acid, coumarins.

Postinhibitins are substances formed from existing but phytoncidally inactive compounds, e.g. through hydrolysis, oxidation. These include cyanogenic glycosides (e.g. prunasin in Padus genus, sambunigrin in elderberries), tuliposides, glucosinolates of garlic and onions. Ingham's concept of the definition of phytoalexins is not quite right. For example, benzoic acid, coniferyl alcohol, scopoletin, resveratrol, safinol are considered as typical phytoalexins. According to Ingham's hypothesis, these substances are formed de novo, after contact with a pathogen. Meanwhile, many plants have these compounds constantly present in their chemical composition, regardless of infection, e.g. Myroxylon balsamum (L.) Harm. Prohibitins, inhibitins and postinhibitins are present in both healthy plants and plants attacked by pathogenic microorganisms, making it possible to isolate these components from plant raw materials and incorporate them into animal and human preparations. The concept of phytoalexins was developed in 1941 by K.O. Miiller and H. Borger. According to this concept, a phytoalexin is a compound that inhibits the development of a pathogen {Guest, D. I. (2017). Phytoalexins, Natural Plant Protection. Encyclopedia of Applied Plant Sciences (Second Edition). B. Thomas, B. G. Murray and D. J. Murphy. Oxford, Academic Press: 124- 128).

The inhibitory factor is an isolated chemical compound, a product of the host cell. Phytoalexin is a non-specific compound in its toxic effects on the pathogen; however, pathogenic organisms may exhibit varying sensitivity to this compound. Phytoalexins include substances of diverse chemical structure, e.g. resveratrol (stilbene), cyclobrassin sulfoxide, momilactone A (diterpene), safinol (polyacetylene), scopoletin (coumarin), 7- hydroxycalamenene (sesquiterpene). Not every phytoncid is also a phytoalexin (does not satisfy Miiller and Borger's rules), however every phytoalexin is a phytoncid. Attention has now turned to phytoalexins due to their strong anti-cancer properties, e.g. brassinin, resveratrol. The simplest phytoalexin is benzoic acid, which is produced by many plants when faced with pathogen intrusion into tissues. Phytoalexins, prohibitins and inhibitins have a defensive role in plants against pathogens, much like antibodies and interferon in humans and animals. When phytoncides and later phytoalexins were discovered, studies aimed at their isolation, stabilization and application in medicine began immediately. This was largely hindered by the intensively developed research on antibiotics and sulfonamides. Cultures of antibiotic-producing bacteria and fungi and the synthesis of sulfonamides were undoubtedly simpler and cheaper, as well as more technologically accessible than phytoncides and phytoalexins. However, due to the growing problem with increasing resistance of bacteria and protozoa to commonly used chemotherapeutics, the concept of using phytoncides in medicine has now been revisited in some countries (Switzerland, Germany, USA, France). At the same time, new therapeutic properties of these compounds have been discovered, e.g. anti- atherosclerotic, hypotensive, hypoglycaemic, oncostatic and estrogenic. As early as the 1950s and 1960s, many studies showed that sulfur phytoncides have a stronger and faster antibacterial effect on Gram-positive and Gram-negative bacteria than some known antibiotics (e.g. bacitracin, neomycin). Additionally, sulphur and isosulphur phytoncides have a diastolic, cholagogic, cholepoietic and hypotensive effect (they reduce elevated blood pressure). They enhance penetration of nutrients from intestines into blood. They inhibit the growth of putrefying bacteria and pathogenic fungi. Have protozoicidal effect. They stimulate secretion of digestive juices, increase appetite, lower cholesterol and glucose levels in blood. Ajoens (garlic oils) inhibit blood cell aggregation, preventing thrombosis. The volatile phytoncides of Asarum sp., Inula sp., merigolds, celandines, garlic or nasturtium kill mycobacteria within 3 minutes, which is faster than carbolic acid (phenol). The phytoncid stilbene resveratrol has anticancer effects, reduces the risk of myocardial infarction, improves coronary circulation and inhibits blood cell aggregation and the formation of atherosclerotic plaques. Additionally, it inhibits the growth of bacteria and fungi and lowers elevated blood glucose levels (H. Rozahski, ./. Kilar, M. Ruda, Influence of phytoncidal plants on maintenance of deer health in organic farm animal husbandry. LXXV Scientific Meeting of the Polish Zootechnical Society. Conference materials, Poznan 2011, p. 209; E. Strzelec, R. Niznikowski, H. Rozahski, M. Klockiewicz, K. Glowacz, G. Czub, A. Darkowska, K. Szymahski, A. Pokrop, Effect of use of herbal feed additive on coccidian invasion level and performance traits in goats, „ Annals of Warsaw University of Life Sciences SGGW Animal Science” 2011, no. 49, p. 11 20). With the development of analytical chemistry and phytochemistry in the 19th and 20^th centuries, new natural compounds with anti-parasitic activity, including protozoicidal activity, were discovered. At that time, quinine, berberine, pelletierine, allantolactone, ascaridol, santonine and others were then introduced into medical treatment, most often in the form of salts with inorganic acids ( Skowrofiski W., Pharmacology. Published by the Polish Society of “Brotherly Help ” of Students of the Academy of Veterinary Medicine, Lwow 1932, p. 183- 191).

In the second half of the 20th century, sulfonamides began to be used in the treatment of protozoal diseases. Unfortunately, with the increasing use of chemical drugs, especially synthetic ones, an increase in parasite resistance to these drugs was observed. Phytoncides and phytoalexins can be a viable alternative to antibiotics and sulfonamides. These include prohibitins, inhibitins, postinhibitins and proper phytoalexins, as well as plant secondary metabolites that exert antimicrobial, disinfectant and antiseptic effects in vivo and in vitro, including compounds that are not (at the current stage of research studies) classified as phytoalexin-type resistance agents. Initially, phytoncides were defined as antibiotics produced by higher plants (B. Czerwiecki, Lexicon specificorm, FIWNIA Warsaw 1950, p. 320 323).

Strong phytoncides are produced by, among others, burnet - Sanguisorba , wormwood - Artemisia Absinthium L., nettles - Urtica , beetroot - Beta , onion - Allium cepa L., corn - Zea, garlic - Allium sativum L. or Allium ursinum L., mustard - Sinapis , hogweed - Heracleum , Turkish pepper - Capsicum annuum L., Padus - Prunus padus L., hornbeam - Carpinus , poplar - Populus , oak - Quercus , jasmine - Jasminus , dogwood - Cornus, yew Taxus , radish - Raphanus , birch - Betula , horseradish - Cochlearia armoracia L., juniper - Juniperus communis L. The volatile phytoncide of garlic kills mycobacteria within 3-5 minutes, thus faster than carbolic acid. Phytoncides are a powerful factor that change the composition of microflora in the atmosphere and soil. According to B.P. Tokin and G.I. Nilov, 1 hectare of juniper tree emits 3 kg of volatile phytoncides per day; this amount is sufficient to sterilise the area of a large city (A. Danysz, Pharmacology and formulation, Ministry of Defence, Warsaw 1955, p. 41 46). The development of Soviet biologists' research on phytoncides dates back to 1928. The greatest amount of research on phytoncides was carried out by Boris Tokin, professor of biology, author of the work published in 1942 entitled "Phytoncides. "Bactericides rastitielnovo proischozdenia (phytoncides)" and the work "Phytoncides" published in 1948, as well as "Medicinal plant remedies (phytoncides)" in In recent years, the search for new antimicrobial substances has led to a significant increase in interest in compounds of plant origin. Review papers on the use of phytoncides in recent years have been presented in: Degtyarik et al., Duka and Ardelean, Ahuja et al. ( Degtyarik S. M., Slobodnitskaya, G. V., Grebneva, E. I., Benetskaya, N. A., Macksimyuk, E. V, & Bespalyi, A. V. (2017). Effect of phytoncides of plants on viability and virulence of etiologic agents of bacterial infections in fish. Bectfi Haii_biniiaa_biiaii akaόqMϋ uaeyK Eenapyci. Cep_bin azpapubix uaeyK; Duka, R., & Ardelean, D. (2010). Phytoncides and phytoalexins vegetal antibiotics. Jurnal Medical Aradean (Arad Medical Journal), 13(3), 19-25; Ahuja, I., R. Kissen and A. M. Bones (2012). "Phytoalexins in defense against pathogens." Trends in Plant Science 17(2): 73-90).

A significant increase can also be observed in reviews and research papers on the use of essential oils. These cover a multidirectional application of essential oils, ranging from veterinary practice and their use in improving animal health and combating bacterial and parasitic diseases, to food preservation and the use of their therapeutic and bactericidal properties ( Aleksic Sabo, V. and P. Knezevic (2019). "Antimicrobial activity of Eucalyptus camaldulensis Dehn. plant extracts and essential oils: A review. " Industrial Crops and Products 132: 413-429; Vergis, ./., G. Palanisamy, R Agarwal and A. Kumar (2013). "Essential Oils as Natural Food Antimicrobial Agents: A Review. " Critical reviews in food science and nutrition 55; Singh, A., A. K. Dwivedy, V. K. Singh, N. Upadhyay, A. K. Chaudhari, S. Das and N. K. Dubey (2019). "Essential oils based formulations as safe preservatives for stored plant masticatories against fungal and mycotoxin contamination: A review. " Biocatalysis and Agricultural Biotechnology 17: 313-317; Pateiro, M., F. J. Barba, R. Dominguez, A. S. SantAna, A. Mousavi Khaneghah, M. Gavahian, B. Gomez and J. M. Lorenzo (2018). "Essential oils as natural additives to prevent oxidation reactions in meat and meat products: A review. " Food Research International 113: 156-166; Raut, J. S. and S. M. Karuppayil (2014). "A status review on the medicinal properties of essential oils. " Industrial Crops and Products 62: 250-264; Nerio, L. S., J. Oliver o-Verbel and E. Stashenko (2010). "Repellent activity of essential oils: A review. " Bioresource Technology 101(1): 372- 378; Deyno, S., A. G. Mtewa, A. Abebe, A. Hymete, E. Makonnen, J. Bazira and P. E. Alele (2019). "Essential oils as topical anti-infective agents: A systematic review and meta analysis. " Complementary Therapies in Medicine 47: 102224).

Regulation (EC) No 1831/2003 retains cocci diostats and introduces histomonostats as a new category of feed additives, while establishing the withdrawal of existing antibiotics from use (and introducing on the market) as feed additives from 1 January 2006, taking into account that the use of antimicrobials as growth promoters involves the risk of selecting bacterial strains resistant to drugs used in human or animal medicine. This issue was closely related to the National Programme for Antibiotic Protection in Poland for 2006-2010, supervised by the Ministry of Health. According to the Programme's guidelines, in order to protect the therapeutic efficacy of antibiotics, particular control should also be exercised over veterinary antibiotic therapy, the use of which should be subject to regulations analogous to those introduced in medicine. Antibiotics used in animal husbandry favour the selection and spread of resistance among microorganisms living therein.

Drug-resistant strains can move along the food chain and colonize the human gastrointestinal tract, creating reservoirs of potential pathogens, including resistance genes, e.g. Salmonella sp., Campylobacter sp., Enterococcus sp., which can then be transmitted to the etiological factors of human infections (H. Pozahski, W. Drymel, Herbal preparations in the prevention of malabsorption syndrome and cirrhosis in animals. Polish Poultry, part I 6/2010, p. 44-46; part II 7/2010, p. 28-30; part III 8/2010, p. 43-44).

Some official coccidiostats have an antibiotic character with antibacterial activity, e.g. lasalocid is an ionophore polyether with anticoccidial and antibacterial activity, isolated from Streptomyces lasaliensis in 1951. Also monensin (an ionophore antibiotic) isolated in 1967 from Streptomyces cinnamonensis has coccidiostatic and antibacterial properties. Maduramicin, produced by Actinomadura rubra , additionally inhibits gram positive bacteria. These antibiotics, despite being developed for use in human medicine, have not found their way into the use therein due to their toxicity and side effects, which exceed their therapeutic value. Despite their known toxicity, the possibility of cross-resistance with other antibiotics and their accumulation in animal products if misused, EFSA has not yet gathered sufficient evidence to withdraw them from animal production. Nevertheless, discussions on this subject are ongoing and are periodically fuelled by protests from various consumer and environmental organisations ( Rozahski H., Drymel W.: Adicox as a source of phytoalexins and phytoncides. Polish Poultry. 12/2010, p. 17-20).

The main problem limiting the effectiveness of antibiotics, sulfonamides and antibiotic growth promoters is antibiotic- and sulfonamide-resistance, i.e. the resistance of microorganisms to the static or lethal effect of chemotherapeutics. Acquisition of resistance by bacteria (as well as fungi and pathogenic protozoa) occurs through selection or adaptation. Resistance to microorganisms may be based on changes in their metabolism, which bypasses the pathway "blocked" by the chemotherapeutic agent, or on the production of enzymes that break down antimicrobial drugs, e.g. a penicillin-resistant strain of Staphylococcus aureus produces the enzyme penicillinase, which breaks down penicillin. This is chromosomal resistance. Resistance to chemotherapeutics (e.g. fluoroquinolones, antibiotics, sulfonamides) can be caused by inhibition of the penetration of the drug into the pathogen cell, e.g. in the case of tetracyclines. Resistance to generally used chemotherapeutics is also transmitted between microorganisms by an extrachromosomal route (plasmids). Antibiotic-sulfonamide- or fluoroquinolone resistance is a property of microorganisms, passed on to the next generation, and it is often called cross-resistance, i.e. a pathogen resistant to one chemotherapeutic agent becomes simultaneously resistant to many others, usually with a similar mechanism of action. Cross-resistance is observed e.g. to tetracyclines, partly to penicillins and cephalosporins, to macrolide antibiotics (A. Danysz, W. Buczko, Compendium of pharmacology and pharmacotherapy, Urban and Partner, Wroclaw -Warsaw 2008).

With the introduction and uncontrolled use of an ever-increasing range of chemotherapeutic agents, and often inappropriately, there is a growing danger of fungal, viral, Actinobacter and Chlamydia infections. The second danger of chemotherapy is enzymes that inactivate antimicrobial and antiparasitic drugs. Apart from beta-lactamase and dehydropeptidase I, enzymes inactivating aminoglycosides have been detected. Most of the antibiotics used in medicine have an adverse (immunosuppressive) effect on the immune system. Therefore, the idea of using additional immunostimulating agents in chemotherapy of infections has emerged (A. Danysz, Compendium of pharmacology and pharmacotherapy. Volumed, Wroclaw 1994, p. 110).

Many phytoncides have simultaneous antimicrobial, antiparasitic and immunostimulating effects, e.g. sesquiterpene lactones from Tanacetum , capsaicin, piperine, or latreoside from Lathraea (H. Rozahski, History of research and application in medicine of domestic parasitic plants of the family Scrophulariaceae and Cuscutaceae, K. Marcinkowski Medical University, Poznan 2004; W. Roeske, Outline of phytotherapy. Pharmacology and formulation of medicinal herbs, PZWL Warsaw 1955, p. 76 78; D. Korniewicz, H. Rozahski, Effectiveness of active substances of plant origin in pigs feeding, „Mag. Wet. ”, Supl. Pigs, 2006, 22 24).

This is evidenced by recent worrying reports of the particular virulence of certain strains of E. coli and Enterococcus faecalis. E. faecalis are resistant to vancomycin (VRE), the 'antibiotic of last resort' produced by Amycolatopsis orientalis. Enterococcal antibiotic resistance genes find their way into other bacteria, such as staphylococci and E. coli. In the 20th century, linezolid, a synthetic antibiotic that inhibits protein synthesis in bacteria, was discovered. However, linezolid-resistant strains of vancomycin-resistant VRE have already emerged. Clinical resistance to metronidazole has been documented in protozoa, e.g. vaginal ciliates, lamblia and many anaerobic bacteria. In vitro, increasing resistance was also observed among trophozoites of dysentery creep as a result of gradually increasing doses of metronidazole (Brunton L.L., Lazo ./., S., Parker K.L., Goodman and Gilman Pharmacology, volume II. Czelej Publisher, Lublin 2007, p. 1127-1129).

Phytoncides can help to address not only bacterial but also protozoal chemotherapeutic resistance.

In animal production, chemoprophylaxis has become dangerous issue. When properly indicated, it can be useful and valuable, but in many cases it is useless or even dangerous (infection with drug-resistant bacteria and protozoa, masking of disease symptoms). Chemoprophylaxis should not be used in circumstances of zootechnical and nutritional negligence, as this undoubtedly leads to veterinary and human chemotherapy being submerged.

The greatest problem is the isolation of phytoncides from plant material and their identification and stabilisation. To date, little research has been done on the antimicrobial properties of pure chemical forms of phytoncides. The antibacterial and fungistatic properties of phytoncides are identified with whole fractions of substances or extracts from medicinal plants rather than with specific compounds (R. Niznikowski, E. Strzelec, H. Rozahski, M. Klockiewicz, K. Glowacz, G. Czub, A. Darkowska, K. Szymahski, A. Pokrop: The effect of addition of phytoncides treatment to concentrate on growth performance and dairy traits in goats. IDF International Symposium on Sheep, Goat and other non-Cow Milk, Athens, May 2011; W. Drymel, H. Rozahski, Use of phytoalexins to improve livestock health. The Polish Branch of World’s Poultry Science Associaton. XXII International Poltry Symposum PB WPSA, „ Science for poultry practice poultry practice for science ”. Olsztyn 2010, p. 151).

AdiFeed R&D has developed a number of phytoncides-based formulations. Despite their introduction on the market, in vitro and in vivo research is still being conducted, as well as field tests on larger populations of farm animals (poultry, fur animals, pigs, ruminants). The production technology of phytoncide preparations is complicated because these compounds are labile (unstable) and reactive (they react, undergo spontaneous transformations). Some of them are lipophilic (dissolve well in organic solvents, e.g. fats, alcohols), others are hydrophilic (dissolve well in water). Therefore, many phytoncidal preparations are biphasic and take the form of emulsions.

Phytoncides belong to a diverse chemical compounds and hence their preparations may be alkaloid, polyphenolic, phenolic, terpene, anthraquinone, iridoid, coumarin, polyacetylene, saponin, or phenylalkylamine. Phytoncides belonging to different chemical groups can either enhance and complement each other's antimicrobial activity, or act antagonistically and cancel each other's activity.

The addition of various metals, e.g. iron, in low concentrations, enhances the antibacterial and antiparasitic activity of phytoncides. The mechanism of antiseptic and antiparasitic action used the oligodynamic effect, It was noted that metals can inhibit the growth of microoganisms and plants if they are in the right concentration in the environment. In the 19th century, the mechanism of the oligodynamic effect could not be explained. Such antimicrobial, antiseptic metals include copper, iron, silver, manganese, mercury, bismuth, tin, zinc (Pozahski H. Antiseptics and disinfectants used in ancient and modern medicine. Drug in Poland, vol. 14 no. 3 ’04, p. 66-77. Vol 13 (154) no. 10/2003, p. 68-81, vol 13 (155) no. 11/2003, p. 94-110; Penzoldt F.: Handbook of clinical pharmacology for use by physicians and students. Printed by Mary a Ziemkiewiczowa, Warsaw 1891, p. 9-42).

Many of them have found lasting application in medical treatment. Soon, attention was also drawn to the "cleanliness" of metal doorknobs (e.g. brass and steel) in hospitals, which, despite being touched by numerous sick patients, do not contain active pathogenic bacteria on their surface, which, in turn, are found in large numbers on wooden objects, floors, plastics or bedding. This phenomenon is explained by the oligodynamic effect. Also, waters, including spring waters, which are rich in various metals, are very poor in bacteria. Before antibiotics and sulfonamides were used in medicine, commonly used chemotherapeutic and antiseptic preparations included bismuth, silver, mercury, iron, copper, gold, platinum, tin and zinc ( Butkiewicz I: General surgery. PZWL Warsaw 1954; p. 31-45). In the 20th century, even antibiotics (e.g. bacitracin with zinc) and sulfonamides (e.g. silver salt of sulphadiazine) were combined with metals for a more effective bacteriostatic effect ( Chrusciel T, Gibihski K. (ed): Lexicon of medicaments. PZWL Warsaw 1991, p. 484-485). The dual mechanism of antimicrobial action of the silver sulfadiazine salt hinders the formation of resistant strains {Ibidem, p. 485). A similar benefit is obtained when phytoncides are combined with metals ( Drymel W., Pozahski H.: Use of phytoalexins to improve livestock health. The Polish Branch of World’s Poultry Science Association. XXII International Poultry Symposium PB WPSA, „ Science for poultry practice poultry practice for science. Olsztyn 2010, p. 151; Korniewicz I)., Rozahski H., Effectiveness of active substances of plant origin in pigs feeding. Mag. Wet., Supl.-Pigs., 2006, 22-24).

If metallic silver is added to distilled water, it acquires bactericidal properties, although the ion concentration under these conditions is only 1: 20,000,000. This effect is called the oligodynamic effect, and its mechanism is not clear, despite many hypotheses (Kostowski W., Herman Z. (ed): Pharmacology. Podstawy farmakoterapii. PZWL Warszawa 2003; 3rd edition; Volume II, p. 271; Kostowski W., Kubikowski P.: Farmakologia. Fundamentals of pharmacotherapy and clinical pharmacology. 3rd edition; PZWL Warsaw 1991, p. 740-741). One hypothesis sees the oligodynamic effect in disrupting the distribution of ionic charges within cell membranes, disrupting the polarity of the cell. Many metals also destabilise (by attaching to) the structure of key proteins (enzymes, channel proteins) and nucleic acids.

Protozoan diseases of animals and humans cause significant morbidity and mortality worldwide. The use of chemotherapeutics to treat protozoan infections has proven to be problematic due to increasing drug resistance, variable efficacy between strains or species and toxicity. There is a strong need to find new effective solutions to treat these diseases.

During the analysis of literature reports and the state of the art, it was observed that published studies are mainly based on the analysis of protozoan inhibitory properties (IC50 and IC100) over a period of 24 to 72 hours. A much smaller percentage of researchers performed analyses with respect to the lethal dose for protozoa.

The use of plant materials, in the treatment of parasitoses, is common in natural and traditional medicine. Previous studies have shown that medicinal plants contain active compounds that exhibit potent activity against protozoa. Examples of commonly used natural antiparasitic agents of plant origin are quinine - an alkaloid from the bark of the quinine tree, artemisinin - a sesquiterpene from Artemisia annua and Artemisia indica (Hygeia Public Health 2014, 49(3): 442-448).

A number of published scientific experimental reports demonstrate the inhibition of protozoan growth (in vitro and in vivo) by the plant extracts and secondary metabolites selected from: essential oils, alkaloids, phenolic compounds ( Natural products as sources of antiprotozoal drugs. Current Opinion in Anti-infective Investigational Drugs 2000; 2, 47 62).

Copper-based complexes are known to act through interactions with protozoan DNA, e.g. Trypanosoma cruzi. Becco et al. demonstrated an inhibitory effect on 50% of the population (IC50) for the compounds they synthesised at 3.9 ± 1.5 to ll.3 ± 3.8 mM, compared to the drug Nifurtimox (6 pM). The IC100 value was achieved for the analysed compounds at concentrations Carat, B., Moreno V, Gambino, D. (2012). New achievements on biological aspects of copper complexes Casiopeinas®: Interaction with DNA and proteins and anti-Trypanosoma cruzi activity. Journal of inorganic biochemistry, 109, 49-56).

Other researchers have proposed vanadium complexes with 2,2'-bipyridine or dipyridine [3,2- a:2',3'-c]phenazine, and salicylaldehyde semicarbazide or its derivative, 5- bromosalicylaldehyde semicarbazide. Similarly as previous researchers, nifurtimox was used as the reference substance. They obtained IC50 results for four variants of the complexes in the range of 13-84 pM {Benitez, J, L. Guggeri, I. Tomaz, G. Arrambide, M. Navarro, J. Costa Pessoa, B. Carat and D. Gambino (2009). "Design of vanadium mixed-ligand complexes as potential anti-protozoa agents. "Journal of Inorganic Biochemistry 103(4): 609-616).

Similar analyses were conducted by two teams of researchers: Martins et al. and Paixao et al. In their study, they focused on using copper ions to create complexes showing properties against Trypanosoma cruzi. The first group of researchers successfully used commonly used antibiotics (levofloxacin and sparfloxacin) to create the complexes {Martins, D. A., Gouvea, L. R., Batista, D. D. G. J., Da Silva, P. B., Louro, S. R, Maria de Nazar έ, C. S., & Teixeira, L. R. (2012). Copper (II) fluoroquinolone complexes with anti-Trypanosoma cruzi activity and DNA binding ability. BioMetals, 25(5), 951-960). On the other hand, Paixao et al., like Benitez et al., created complexes of the general formula [Cu(N_0) (N_N)]²⁺, using 2- methoxybenzhydrazide, 4-methoxybenzhydrazide and three a-diimine ligands: 1,10- phenanthroline, 2,2'-bipyridine and 4-4'-dimethoxy-2-2'-bipyridine {Paixao, D. A., Lopes, C. D., Carneiro, Z. A., Sousa, L. M., de Oliveira, L. P., Lopes, N. P., Pivatto M., Chaves J.D.S., de Almeida M.V., Ellena J., Moreira M.B., Netto A.V.G., de Oliveira R.J., Guilardi S., de Albuquerque S., Guerra W Moreira, M. B. (2019). In vitro anti-Trypanosoma cruzi activity of ternary copper (II) complexes and in vivo evaluation of the most promising complex. Biomedicine & Pharmacotherapy, 109, 157-166). Sulfoaminoamide complexes with copper and zinc 8-aminoquinoline groups showed efficacy against pathogenic strains of Leishmania braziliensis , chagasi and Trypanosoma cruzi. Their lowest IC50 was determined to be 0.35 mM (about 0.034%) under laboratory conditions ( Everson da Silva, L, Teixeira, D. S. ./., Nunes Maciel, E., Korting Nunes, R., Eger, I., Steindel, M, & Andrade Rebelo, R (2010). In vitro antiprotozoal evaluation of zinc and copper complexes based on sulfonamides containing 8-aminoquinoline ligands. Letters in Drug Design & Discovery, 7(9), 679-685).

Other synthetic metal complexes i.e. manganese, cobalt, nickel in the form of 4'-(2- ferrocenyl)-2,2':6''2''-terpyridinium derivatives under in-vitro conditions were very effective at a concentration of 1.1 mM against Plasmodium falciparum. The authors demonstrated the effectiveness of mixtures of manganese, iron, cobalt, nickel and copper salts ( Al-Khodir , F. A. L, & Refat, M. S. (2017). Investigation of coordination ability ofMn (II), Fe (III), Co (II), Ni (II), and Cu (II) with metronidazole, the antiprotozoal drug, in alkaline media: Synthesis and spectroscopic studies. Russian Journal of General Chemistry, 87(4), 873-879).

The possibility of effective complex formation by a commonly used antibiotic with strong antiprotozoal activity (Metronidazole), with metals including Mn(II), Fe(III), Co(II), Ni(II), and Cu(II) has also been demonstrated ( Al-Khodir , F. A. I. and M. S. Refat (2017). "Investigation of coordination ability of Mn(II), Fe(III), Co(II), Ni(II), and Cu(I I) with metronidazole, the antiprotozoal drug, in alkaline media: Synthesis and spectroscopic studies. "Russian Journal of General Chemistry 87(4): 873-879).

Enhancement of the activity of antiprotozoan metal ions of copper and zinc in synthetic organic complexes of imidazopyridines and diarylpiperidines has also found its patent protection. Thus, the patents US6291480 B1 and US20060178358 B1 relates to the activity of diarylpyridyl derivatives against Toxoplasma gondii , Trypanosoma cruzi and Emeria species : tenella, acervulina, necatrix, brunetti maxima. US20110207701 A1 is another example of antiprotozoal applications of metal complexes including copper and low molecular weight bioorganic compounds.

Previous studies on antimicrobial properties have shown very strong effects of essential oils. Escobar, P et al. conducted studies on the antimicrobial properties of five plants of the genus Lippi. They analysed the extracted oils in terms of inhibition of the development of protozoa on Trypanosoma cruzi and Leishmania chagasi , with reference to nifurtimox. They obtained IC50 values from 4.4 to >100 pg/ml, while for nifurtimox the value was 0.3-0.4 pg/ml {Escobar, P., Milena Leal, S., Herrera, L. V., Martinez, ./. R., & Stashenko, E. (2010). Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components. Memorias do Instituto Oswaldo Cruz, 105(2), 184-190).

Similarly, the application W02008101131 A1 relates to a composition for killing or repelling ectoparasites and/or pests, comprising at least 3% Lippia javanica essential oil and at least one other essential oil.

Another group of researchers demonstrated the effect of essential oils from Annona coriacea on Trypanosoma cruzi and different leishmania species {Leishmania (L.): amazonensis, braziliensis, chagasi, major). Two compounds commonly used for leishmaniasis were used for comparative analysis: pentamidine and benznidazole. The values obtained for the essential oils (39.93-261.20 pg/mL) were significantly higher than those for the reference drugs tested (0.06-022 pg/mL and 45.02 pg/mL, respectively) ( Siqueira , C. A. T, J. Oliani, A. Sartoratto, C. L. Queiroga, P. R. H. Moreno, J. Q. Reirndo, A. G. Tempone and D. C. H. Fischer (2011). "Chemical constituents of the volatile oil from leaves of Annona coriacea and in vitro antiprotozoal activity. " Revista Brasileira de Farmacognosia 21: 0-0).

Perez et al. in their review paper collected information on the antiprotozoal properties, IC50 (Giardia lamblia , Trichomonas vaginalis , Leishmania sp, Trypanosoma cruzi) for thyme, garlic, basil, lavender, tea or yarrow oils, among others. They demonstrated antiprotozoal properties of essential oils in a very wide range of concentrations, from 8.3 ng/ml to 8mg/ml {Perez, S., M. Ramos-Lopez, E. Sdnchez-Miranda, M. Fresdn-Orozco and J. Perez-Ramos (2012). "Antiprotozoa activity of some essential oils. " Journal of medicinal plant research 6: 2901-2908).

Monzote et al. collected literature reports on the antiparasitic properties of essential oils between 1988 and 2012. They present a significant increase in the interest and amount of research on the use of essential oils against protozoa {Monzote, L., O. Alarcon and W. Setzer (2012). "Antiprotozoal Activity of Essential Oils." Agriculturae Conspectus Scientificus 77: 167-175).

On the other hand, Moon et al, in their research paper, presented the protozoicidal properties of two lavender oils against Giardia duodenalis , Trichomonas vaginalis and Hexamita inflata. They demonstrated that a concentration of 0.1% of lavender oil has a protozoicidal effect against the analysed protozoa {Moon, T, J. Wilkinson and H. Cavanagh (2006). "Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata. "Parasitology research 99: 722-728).

On the other hand, the application EP2070427 A1 relates to the use of at least one essential oil compound selected from the group consisting of cinnamaldehyde, 2-decenal and nerolidol as, or in the preparation of, a histomonastat. Preferably, at least one essential oil compound is additionally combined with at least one compound selected from the group consisting of p- cymene, thymol, salicylaldehyde, tea tree oil, peppermint oil, cuminaldehyde, cinnamic acid, cinnamic alcohol, farnesal and farnesylacetone.

The application EP2119363 A2 relates to an antimicrobial composition based on plant essential oils, of enhanced anti-microbial effectiveness, comprising: at least two plant essential oils as a major component; and a small but antimicrobial enhancing effective amount of an enhancer selected from the group consisting of polyionic organic enhancers (e.g. polyetheyleneimine) and polyionic inorganic enhancers (e.g. sodium tripolyphosphate, sodium hexametaphosphate).

The application E1S2014106012 AA relates to a composition comprising: an essential oil selected from the group consisting of anise oil, rosemary oil, calendula oil, tea tree oil, sassafras oil, quassia oil, cinnamon oil, clove oil, eucalyptus oil, lavender oil, peppermint oil, or combinations thereof; from about 10% to about 30% (v/v) isopropyl alcohol; from about 30% to about 50% (v/v) isopropyl myristate; between about 5% and about 20% (v/v) of a silicone oil; and from about 5% to about 25% (v/v) capric/caprylic trigylceride.

The document EP 1512409 B1 relates to an aqueous composition for the treatment of headlice and their eggs and which includes as its active ingredients at least one essential oil characterised in that the composition further includes an infusion of: dried peppermint leaves, a tea, and garlic. Wherein a disclosed method of manufacture of said composition for the treatment of headlice include the steps of: making an infusion of peppermint leaves, tea and garlic in boiling water and allowing to cool, adding essential oils to the cooled infusion and then mixing the cooled infusion with surfactants and thickening agents to form a gel.

Patent EP 1089745 B1 relates to the use of extract of oregano or a metabolic product of the extract of oregano for the manufacture of a medicament for reducing or eliminating intestinal amoeba selected from the group consisting of Entamoeba hartmanni , Blastocystis hominis , Endolimax nana , and Entamoeba histolytica in humans in need thereof wherein such a medicament is adapted for administration in the form of an emulsified, sustained release tablet comprising carvacrol as an active ingredient.

On the other hand document US2014037698 AA (EP2666364 Bl) relates to an additive for animal feed comprising the combination of a salt of an organic acid with at least one active ingredient of plant origin, this combination partially coated with vegetable oils and/or fats. Wherein the active ingredients of plant origin comprise essential oils selected from the group consisting of ginger, piperine, oregano, thymol, carvacrol, cinnamaldehyde, garlic, and combinations thereof. On the other hand, the organic acid are selected from the group consisting of butyric, propionic, formic, lactic, citric, lauric, capric, caprylic, caproic, and acetic. Wherein the disclosed food additive has a antiprotozoal properties.

The aim of the invention is to provide a new composition for controlling protozoa.

The invention relates to a veterinary composition containing as an active substance either glaucine or an extract from a herb of the Glaucium sp., characterised in that said active substance is in a complex with a mixture of organic acids comprising four acids selected from the group comprising: valeric acid, isovaleric acid, lactic acid, butyric acid, acetic acid, propionic acid, formic acid, benzoic acid, pelargonic acid, salicylic acid, malonic acid, citric acid, phthalic acid, tartaric acid, oxalic acid, malic acid, shikimic acid, fumaric acid, mandelic acid cinnamic or derivatives thereof and a metal selected from the group comprising molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, their salts or oxides for the treatment and/or prevention of diseases caused by protozoa of Apicomplexa phylum in animals.

Preferably, the acids in the mixture of organic acids are mixed in a ratio of 1 : 1 : 1 : 1.

Preferably, the mixture of organic acids is a mixture of acetic acid, propionic acid, lactic acid and formic acid.

The invention also relates to a method of manufacturing a veterinary composition for the treatment and/or prevention of diseases caused by protozoa of Apicomplexa phylum in animals, containing either glaucine or an extract from a herb the Glaucium sp. as the active substance, according to invention, characterised in that it comprises the following steps: a) either mixing of an extract from herb of the Glaucium sp. with a mixture of organic acids and addition of a catalyst, or introduction of a catalyst into a mixture of acids and addition of glaucine, wherein the mixture of organic acids comprise four acids chosen from the group comprising: valeric acid, isovaleric acid, lactic acid, butyric acid, acetic acid, propionic acid, formic acid, benzoic acid, pelargonic acid, salicylic acid, malonic acid, citric acid, phthalic acid, tartaric acid, oxalic acid, malic acid, shikimic acid, fumaric acid, almond acid, cinnamic acid or derivatives thereof; b) adding a metal selected from the group comprising: molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, their salts or oxides; c) heating the mixture obtained in step (b) with the catalyst to boiling point and continuing the heating at boiling point under reflux for 20-120 min.; d) leaving the reaction product to cool for a period of between 10 and 24 hours; e) filtering the cooled reaction product.

Preferably, in step a) the active ingredient is mixed with a mixture of organic acids in a weight ratio of 1: 1 to 10: 1.

Preferably, the acids in the organic acid mixture are mixed in a ratio of 1 : 1 : 1 : 1.

Preferably, a mixture of cobalt sulphate, ammonium molybdate and manganese chloride or sulphate is used as a catalyst.

The invention also relates to the use of compositions according to the invention for the prevention and/or treatment of diseases caused by protozoa of the Apicomplexa phylum ( Apicomplexa ) in animals.

The invention provides the following favourable effects:

• the protozoicidal properties of the composition ensure complete elimination of infection;

• the composition according to the invention is effective in low concentrations;

• the composition according to the invention exhibits a broad spectrum of action - i.e. it exhibits good killing activity against many species of protozoa;

• the composition according to the invention can be an alternative to protozoal chemotherapeutics (Antiprotozoal), such as, for example, metronidazole, albendazole, tinidazole, amprolium, lasalocid, salinomycin, robenidine, nicarbazin, monensin, decoquinate, diclazuril, or it can also be an additive to antiprotozoal chemotherapeutics, reducing the risk of resistance to a given drug.

The invention is set out in detail in the following examples, wherein all tests and experimental procedures described below were carried out using commercially available test kits, reagents and devices, following the recommendations of the manufacturers of the kits, reagents and devices used, unless otherwise expressly indicated. All test parameters were measured using standard, well-known methods used in the field of invention.

All raw materials used in the study are approved for both animal and human nutrition by the relevant directives and authorities. The selection of raw materials was made on the basis of Codex Alimentarius, i.e. the Codex Alimentarius established by FAO and WHO, Der Deutsche Arzneimittel-Codex (DAC), guidelines of the European Food Safety Authority (EFSA) and Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 August 2003 on additives for use in animal nutrition. In addition, the essential oils used in the study met the requirements of the European Pharmacopoeia, the Swiss Pharmacopoeia and Der Deutsche Arzneimittel-Codex (DAC).

Whereas for in vitro tests of antiprotozoal activity of the composition according to the invention five reference organisms representing taxonomic groups to which pathogenic protozoa belong were selected, i.e:

• Amoeba proteus - Chaos diffluens - a protozoan of the order Euamoebida, belonging to fifth supergroup of the Amoebozoa , living in waters.

• Paramecium caudatum - a slipper animalcule representing the Ciliata orachs, living in waters.

• Gregarina blattarum - gregarine isolated from cockroaches, representing the phylum Apicomplexa , living in the digestive tracts or body cavities of invertebrates.

• Euglena gracilis - a protozoan living in water, representing the flagellates - Mastigophora , family Euglenaceae.

• Trichomonas hominis - a protozoan living in the human colon, representing the Trichomonadidae .

Amoeba , Paramecium , Trichomonas and Euglena were observed under a microscope on watch glasses with viscose wool fibres (to facilitate observation) in a drop of water from the culture they came from. Different concentrations of the test compositions were introduced to the test samples, establishing an LD50 dose (50% mortality) and an LD100 dose (100% mortality). In all cases, 4-fold replicates of the test were used together with a blank test.

The gregarines were isolated from the cockroaches and, after being placed on a watch slide, were treated with the products at different concentrations in Ringer's solution. Each sample contained ten individuals. The lethal concentration of the substance for 50% and 100% of the individuals (LD50, LD100) within 3 minutes was determined. Isolation of gregarines from cockroaches was performed on the basis of the method of isolation of gregarines from beetles proposed by J. Moraczewski ( Moraczewski ./. : Exercises in the zoology of invertebrates. 1st Edition, PWN, Warsaw 1974, p.29-31, p. 285-292 ).

Identification of individual protozoa was made on the basis of their descriptions and drawings after W.A. Dogiel and J. Hempel-Zawitkowska ( Dogiel W.A.: Invertebrate zoology. 3rd edition, National Agricultural and Forest Publishing House 1972; Hempel-Zawitkowska J., Galka B., Kalihska B., Kamionek M., Komosihska H, Pezowicz E. Podsiadlo E., Sulgostowska T.: Zoology for agricultural universities. Scientific Publishing House PWN 2008).

The compositions according to the invention, negative and positive controls, were dissolved in an aqueous solution of polysorbate 80 (0.05%) before application to a watch slide. No lethal effect of polysorbate 80 at the above concentration was observed.

Example 1.

A combination (mixture and complex) of the alkaloid glaucine with organic acids and copper or zinc.

In this non-limiting example, the following two compositions were prepared: a) composition I - i.e., a composition of glaucine with a mixture of organic acids and copper in the form of copper carbonate; b) composition II - i.e., a composition of glaucine with a mixture of organic acids and zinc in the form of zinc carbonate (but other salts or oxides may also be used).

Although in this non-limiting example copper or zinc is used as the metal component, other metals, e.g. molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, salts thereof, or oxides thereof, may also be used to produce the composition according to the invention. In order to prepare composition I, a catalyst (comprising a cobalt sulfate, ammonium molybdate and manganese chloride mixed in a ratio of 1 : 1 : 1 : 1) in an amount of 0.3 g was introduced into 10 ml of an acid mixture (containing acetic acid, propionic acid, lactic acid and formic acid mixed in a ratio of 1:1:1: 1). Next 10 g of glaucine and 1 g of copper carbonate were introduced to said mixture. The mixture was heated at boiling point until the colour changed, under reflux for 20 minutes. The mixture was then left to cool (for 10 hours). After this time the reaction product was filtered through filter paper.

Composition II was prepared analogously to composition I, except that lg of zinc carbonate was added instead of copper carbonate. Compositions I and II were then analysed for their antiprotozoal properties. For this purpose, both compositions were diluted: 0.001% to 1%, after which protozoa were placed in each dilution.

The individual components of the compositions according to inventions were also analysed separately for antiprotozoal properties. The tested preparations were dissolved in an aqueous solution of polysorbate 80 (0.05%) prior to the application to a watch glass. No killing effect of polysorbate 80 in the above concentration was observed. Observation under a fluorescence microscope with phase contrast was carried out. Protozoicidal activity was considered effective when the death of 50% and 100% of individuals occurred within 3 minutes. The control antiprotozoal substances were CH - chloramphenicol and M - metronidazole. The results obtained from the antiprotozoal activity test are presented in Table 1. The results of the analysis showed that the cidal and static activity in the compositions according to invention and after the reaction was higher than that of the substances individually testes, included in the reaction mixtures and complexes. Compositions I and II show many times stronger (potentiation) protozoal activity than each of these components separately.

All the ingredients used in the compositions according to the invention are approved for both animal and human nutrition by the relevant directives and authorities, which, combined with their high efficacy, allows their use in the treatment and/or prevention of parasitoses in animals caused by protozoa, In particular, histomoniasis (caused by Histomonas meleagridis ), coccidiosis (caused by Eimerid), cryptosporidiosis (caused by Cryptosporidium ), trichomoniasis (caused by Trichomona ), babesiosis (caused by Babesia ), amoebiasis (caused by Amoeba ) or protozoa of Apicomplexa phylum (Apicomplexa).

Table 1. LD₅₀, LD₁₀₀ values for compositions I and II, determined for selected protozoa.

*CH - chloramphenicol; **M - metronidazole

Example 2.

Combination (complex and mixture) of alkaloid extract from herb of Glaucium sp. with a mixture of acids and either copper or zinc.

To obtain an extract from herb of the Glaucium sp., 100 g of dry and crushed herb of Glaucium sp. was poured into 500 ml of a mixture: isopropanol + ethyl acetate + water, distilled in the ratio 50:30:20 with succinic acid (5 g). It was heated under a reflux condenser at boiling point for 30 minutes and then allowed to cool for 24 hours. It was filtered through a filter paper.

In this non-limiting example of implementation, the following two compositions were prepared: a) composition III - i.e., a composition of an extract from the herb of Glaucium sp. with a mixture of organic acids and copper in the form of copper carbonate b) composition IV - i.e., a composition of an extract from the herb of Glaucium sp. with a mixture of organic acids and zinc in the form of zinc carbonate (but other salts or oxides can also be used).

In order to prepare the composition III, a 1.5g of catalyst mixture (containing cobalt sulphate, ammonium molybdate and manganese sulphate mixed 1:1:1) and 5g of copper carbonate and 50 ml of acid mixture (containing acetic acid, propionic acid, lactic acid and formic acid mixed 1 : 1 : 1 : 1) were added to 500 ml of the obtained extract.

Although in this non-limiting example of implementation the mixture of acids comprises acetic acid, propionic acid, lactic acid and formic acid, in the method according to the invention any four acids selected from the group consisting of valerian acid, isovalerian, lactic, butyric, acetic, propionic, formic, benzoic, pelargonic, salicylic, malonic, citric, phthalic, tartaric, oxalic, malic, shikimic, fumaric, mandelic, cinnamic or their derivatives.

The whole mixture was heated at boiling point, until the colour changed, under reflux for 120 minutes. The mixture was then allowed to cool (for 24 hours) to obtain a clear solution (mono-, bi- or tri-phase). After this time, the reaction product was filtered through filter paper. Composition IV was prepared analogously to composition III, except that 5g of zinc carbonate was added instead of copper carbonate. Compositions III and IV were then analysed for their antiprotozoal properties analogously to Example 1, and the results are shown in Table 2. The results of the analysis showed that the cidal and static activity in the complex compositions according to invention and after the reaction was higher than that of the substances individually tested, included in the reaction mixtures and complexes. Compositions III and IV showed many times stronger (potentiation) protozoal activity than each of these components separately.

All the ingredients used in the compositions according to the invention are approved for both animal and human nutrition by the relevant directives and authorities, which, combined with their high efficacy, allows their use in the treatment and/or prevention of parasitoses in animals caused by protozoa, In particular, histomoniasis (caused by Histomonas meleagridis ), coccidiosis (caused by Eimerid), cryptosporidiosis (caused by Cryptosporidium ), trichomoniasis (caused by Trichomona ), babesiosis (caused by Babesia ), amoebiasis (caused by Amoeba ) or protozoa of Apicomplex a phylum (Apicomplexa).

Table 2. LD50, LD100 values for compositions III and IV, determined for selected protozoa.

*CH - chloramphenicol; **M - metronidazole

Claims

Patent claims

1. A veterinary composition containing as an active substance either glaucine or an extract from a herb of the Glaucium sp., characterised in that said active substance is in a complex with a mixture of organic acids comprising four acids selected from the group comprising: valeric acid, isovaleric acid, lactic acid, butyric acid, acetic acid, propionic acid, formic acid, benzoic acid, pelargonic acid, salicylic acid, malonic acid, citric acid, phthalic acid, tartaric acid, oxalic acid, malic acid, shikimic acid, fumaric acid, mandelic acid cinnamic or derivatives thereof and a metal selected from the group comprising molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, their salts or oxides for the treatment and/or prevention of diseases caused by protozoa of Apicomplexa phylum in animals.

2. The composition according to claim 1, characterised in that the acids in the mixture of organic acids are mixed in a ratio of 1 : 1 : 1 : 1.

3. The composition according to claim 1 or 2, characterised in that the mixture of organic acids is a mixture of acetic acid, propionic acid, lactic acid and formic acid.

4. A method of manufacturing a veterinary composition for the treatment and/or prevention of diseases caused by protozoa of Apicomplexa phylum in animals, containing either glaucine or an extract from a herb the Glaucium sp. as the active substance, according to any of the preceding claims from 1 to 3, characterised in that it comprises the following steps: a) either mixing of an extract from herb of the Glaucium sp. with a mixture of organic acids and addition of a catalyst, or introduction of a catalyst into a mixture of acids and addition of glaucine, wherein the mixture of organic acids comprise four acids chosen from the group comprising: valeric acid, isovaleric acid, lactic acid, butyric acid, acetic acid, propionic acid, formic acid, benzoic acid, pelargonic acid, salicylic acid, malonic acid, citric acid, phthalic acid, tartaric acid, oxalic acid, malic acid, shikimic acid, fumaric acid, almond acid, cinnamic acid or derivatives thereof; b) adding a metal selected from the group comprising: molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, their salts or oxides; c) heating the mixture obtained in step (b) with the catalyst to boiling point and continuing the heating at boiling point under reflux for 20-120 min.; d) leaving the reaction product to cool for a period of between 10 and 24 hours; e) filtering the cooled reaction product.

5. The method according to claim 4, characterised in that in step a) the active ingredient is mixed with a mixture of organic acids in a weight ratio of 1 : 1 to 10: 1.

6. The method according to claim 4 or 5, characterised in that the acids in the organic acid mixture are mixed in a ratio of 1 : 1 : 1 : 1.

7. The method according to any of the preceding claims from 4 to 6, characterised in that the mixture of organic acids is a mixture of acetic acid, propionic acid, lactic acid and formic acid.

8. The method according to any of the preceding claims from 4 to 7, characterised in that a mixture of cobalt sulphate, ammonium molybdate and manganese chloride or sulphate is used as a catalyst.